Phase 1b study of pasireotide, everolimus, and selective internal radioembolization therapy for unresectable neuroendocrine tumors with hepatic metastases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase 1b study of pasireotide, everolimus, and selective internal radioembolization therapy for unresectable neuroendocrine tumors with hepatic metastases

Published:2018-02-16 Issue:9 Volume:124 Page:1992-2000
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Kim Hyun S.¹^ORCID,Shaib Walid L.²^ORCID,Zhang Chao³,Nagaraju Ganji Purnachandra²^ORCID,Wu Christina²,Alese Olatunji B.²,Chen Zhengjia³,Brutcher Edith²,Renfroe Meredith⁴,El-Rayes Bassel F.²^ORCID

Affiliation:

1. Division of Interventional Radiology, Yale Cancer Center; Yale School of Medicine; New Haven Connecticut

2. Department of Hematology and Oncology, Winship Cancer Institute; Emory University; Atlanta Georgia

3. Department of Biostatistics; Emory University; Atlanta Georgia

4. Clinical Trials Office, Winship Cancer Institute; Emory University; Atlanta Georgia

Funder

Cancer Institute in Atlanta, Georgia

Novartis Foundation for Sustainable Development

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference42 articles.

1. Result of liver resection as treatment for metastases from noncolorectal cancer;Benevento;J Surg Oncol.,2000

2. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID study group;Rinke;J Clin Oncol.,2009

3. Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study;Caplin;Endocr Relat Cancer.,2016

4. Phase 3 trial of 177Lu-dotatate for midgut neuroendocrine tumors;Strosberg;N Engl J Med.,2017

5. First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas;Strosberg;Cancer.,2011

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multidisciplinary Delphi Consensus on Safety of Combining Transarterial Radioembolization with Yttrium-90 Microspheres with Systemic Anticancer Agents for the Treatment of Liver Malignancy;Journal of Vascular and Interventional Radiology;2024-09

2. Hepatic Radioembolization;PET Clinics;2024-07

3. Emerging Treatment Options for Neuroendocrine Neoplasms of Unknown Primary Origin: Current Evidence and Future Perspectives;Cancers;2024-05-27

4. Liver-Directed Locoregional Therapies for Neuroendocrine Liver Metastases: Recent Advances and Management;Current Oncology;2024-04-05

5. Statistical methods and data visualisation of patient-reported outcomes in early phase dose-finding oncology trials: a methodological review;eClinicalMedicine;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3